Pharmaxis Ltd.

Pharmaxis Ltd.

Sector: Pharmaceutical Preparations Region: Australia

: | ASX: PXS | OTC Markets: PXSLY

Similar to: BioGaia AB, Hutchison China MediTech Ltd., BioAlliance Pharma SA

Pharmaxis Ltd. operates as a specialty pharmaceutical company which develops and commercializes therapeutic products for chronic respiratory disorders, autoimmune diseases and the development of an improved lung function test. The company's products include Aridol for the assessment of asthma, Bronchitol for cystic fibrosis, bronchiectasis and chronic obstructive pulmonary disease, PXS25 for the treatment of lung fibrosis and ASM8 and PXS4159 for asthma. Pharmaxis was founded by Brett Charlton and William B. Cowden on May 29, 1998 and is headquartered in Frenchs Forest, Australia.

News & Analysis

You may also be interested in: